We are live on ! Find out more
IMUX icon

Immunic
IMUX

55 hedge funds and large institutions have $130M invested in Immunic in 2026 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 21 increasing their positions, 15 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

436% more call options, than puts

Call options by funds: $4.64M | Put options by funds: $865K

80% more capital invested

Capital invested by funds: $72.1M → $130M (+$57.6M)

56.98% more ownership

Funds ownership: 4.98% → 61.95% (+57%)

40% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 15

27% less funds holding

Funds holding: 75 → 55 (-20)

59% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 32

Holders
55
Holders Change
-20
Holders Change %
-26.67%
% of All Funds
0.66%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
21
Reduced
15
Closed
32
Calls
$4.64M
Puts
$865K
Net Calls
+$3.77M
Net Calls Change
+$3.33M

Top Buyers

Rank Fund Capital Flow
1
B
Braidwell
Connecticut
+$7.96M
2
JHC
Jones Hill Capital
New York
+$6.66M
3
WP
Woodline Partners
California
+$4.62M
4
Millennium Management
Millennium Management
New York
+$4.47M
5
LCM
Laurion Capital Management
New York
+$2.74M

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$3.76M
2
6CM
683 Capital Management
New York
-$1.21M
3
Renaissance Technologies
Renaissance Technologies
New York
-$1.02M
4
State Street
State Street
Massachusetts
-$628K
5
HF
HRT Financial
New York
-$547K

IMUX Hedge Fund Activity: Q2 2026 in Review

55 of the 8,305 institutional investors tracked by Wall St. Rank reported a position in Immunic (IMUX) for Q2 2026, worth a combined $130M — up 80% from $72.1M a quarter earlier.

Sellers outnumbered buyers: 32 funds closed out of IMUX and 13 opened new positions — a net loss of 19 holders — while 15 trimmed existing stakes and 21 added.

The largest buyer was Braidwell, opening a new position worth an estimated $7.96M. The largest seller was Morgan Stanley, cutting an estimated $3.76M.

  • 55 institutional investors held Immunic (IMUX) as of Q2 2026, down from 75 in Q1 2026.
  • Funds reported $130M of Immunic stock for Q2 2026, up 80% quarter-over-quarter.
  • 13 funds opened new Immunic positions in Q2 2026 and 32 closed out, a net change of -19 holders.
  • The largest Immunic buyer in Q2 2026 was Braidwell, an estimated $7.96M added.
  • The largest Immunic seller in Q2 2026 was Morgan Stanley, an estimated $3.76M sold.

Based on aggregated 13F filings for Q2 2026.